You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 2020012620093980706468
conjunctiva
Oops, an error occurred! Code: 202001262009391c184f91
disease gene mapping
Oops, an error occurred! Code: 20200126200939a70d6a0c
gene/expression
Oops, an error occurred! Code: 2020012620093957b88695
gene microarray
Oops, an error occurred! Code: 20200126200939d70071a8
genetics
Oops, an error occurred! Code: 20200126200939f2d0498a
immunohistochemistry
Oops, an error occurred! Code: 2020012620093925c01e6b
iris
Oops, an error occurred! Code: 20200126200939ffc3e5e5
melanoma
Oops, an error occurred! Code: 202001262009397e134ffd
oncology
Oops, an error occurred! Code: 20200126200939ee040bd6
pathology: experimental
Oops, an error occurred! Code: 2020012620093903eb9435
pathology: human
Oops, an error occurred! Code: 2020012620093986306ed1
pathology techniques
Oops, an error occurred! Code: 20200126200939a90e6f19
tumors
Oops, an error occurred! Code: 20200126200939c2d77ea1
uvea
Oops, an error occurred! Code: 202001262009397c9e452b
vision and action
Oops, an error occurred! Code: 202001262009394736de9c
visual acuity
Oops, an error occurred! Code: 20200126200939992d1acc
uveal melanoma
Oops, an error occurred! Code: 2020012620093907c0b270
conjunctival melanoma
Oops, an error occurred! Code: 20200126200939b7609453
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 20200126200939385c4b28
pathology
Oops, an error occurred! Code: 202001262009392a2bee81
translational studies
Oops, an error occurred! Code: 20200126200939474cd768